StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Mereo BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Mereo BioPharma's price to book ratio was 1.7× on Nov 11, 2026, against 6.3× a year earlier. Over the last 5 years it ranged from 0.6× to 12.9×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×+0.3
2025Dec 31, 20251.4×−6.2
2024Oct 31, 20247.6×+2.2
2023Dec 29, 20235.4×+4.5
2022Dec 30, 20220.9×–

More Mereo BioPharma figures

See a number that looks wrong?